Convenient one-pot synthesis and biological evaluation of novel 3,5-dimethyl-1H-pyrazole-1-carbothiohydrazide derivatives as new anti-tumor agents against both liver carcinoma (HepG2) and lung carcinoma (A549) cell lines

Marwa Fouad,Mahmoud Elaasser

DOI: https://doi.org/10.26434/chemrxiv-2023-dkr1h

2023-12-22

Abstract:Pyrazle constituents have garnered consideration mainly because of their presumed biological and curative properties. Therefore, the goal of the presented research is to create some novel pyrazole-1-carbothiohydrazide derivatives with predicted biological functions using an accessible one-pot synthesis employing 3,5-dimethyl-1H-pyrazole-1-carbothiohydrazide (1) as a facile antecedent. The component 1 and 1,3-diphenylpropane-1,3-dione (2) interacted resulting in pyrazole derivative 3 when ethanol or acetic acid were supplied. However, when the substance 1 interacted in ethanol with either 2 or acetyl acetone 5, using the catalytic proportion of triethylamine offered, it yielded compounds 4 and 6 respectively. Ingredient 1 was subjected to additional reactions with ethyl cyanoacetate (7), stearic acid 10, or equivalent carboxylic acids 12a-c, resulted in the formation of 9, 11, and 13a-c consequently. Additionally, when 1 was combined with α-haloketones 14 or 16, it yielded the corresponding 1,3,4-thiadiazine derivatives, 15 and 17. Every designed product's chemical structure was established according to spectroscopic and analytical results. The cytotoxic activities of the synthesized chemicals were assessed against two carcinoma cell lines, and compared to the standard drug Cisplatin using the colorimetric MTT assay. Furthermore, the results revealed that chemical 17 was the most active against the liver and lung carcinoma cell lines giving potent IC50 value of 5.35 and 8.74 μM, respectively, compared with reference drug cisplatin (3.78 and 6.39 μM). Interestingly, ingredient 17 when evaluated for their toxicity against normal lung fibroblast (MRC-5) cells exhibited low toxic effects indicating the safe use. Generally, our results exerted promising bioactive compounds.

Chemistry

What problem does this paper attempt to address?

The main objective of this paper is to synthesize a series of novel 3,5-dimethyl-1H-pyrazole-1-thiocarbamoyl derivatives and evaluate their potential as anticancer drugs. The researchers used a one-pot synthesis method to prepare these compounds and generated various pyrazole and 1,3,4-thiadiazole derivatives by reacting with different diketones such as 1,3-diphenylpropanone (2) or acetylacetone (5). In addition, 1,3,4-thiadiazole derivatives were obtained by reacting with α-haloketones. The experimental section provides a detailed description of the conditions for each chemical reaction and characterization of the products, including melting points, infrared spectra, nuclear magnetic resonance spectra, and mass spectrometry analysis. The synthesized compounds were then tested for their cytotoxicity against hepatocellular carcinoma (HepG2) and lung cancer (A549) cell lines. The results showed that compound 17 exhibited the strongest antitumor activity, with IC50 values of 5.35 and 8.74 μM, compared to the standard drug cisplatin with IC50 values of 3.78 and 6.39 μM, demonstrating similar or better efficacy. Moreover, compound 17 showed low toxicity towards normal lung fibroblast cells (MRC-5), indicating its potential for better safety. In summary, this paper aims to develop new potential anticancer compounds and demonstrates significant anticancer activity of certain synthetic products through biological evaluation, providing possible directions for the development of new chemotherapy drugs.

Convenient one-pot synthesis and biological evaluation of novel 3,5-dimethyl-1H-pyrazole-1-carbothiohydrazide derivatives as new anti-tumor agents against both liver carcinoma (HepG2) and lung carcinoma (A549) cell lines

Convenient One‐Pot Synthesis and Biological Evaluation of New 3,5‐Dimethyl‐1H‐pyrazole‐1‐carbothiohydrazide Derivatives as Anti‐Tumor Agents

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents

Synthesis and Anticancer Activity of Some New Pyrazolo[3,4-d]pyrimidin-4-one Derivatives

Synthesis and anticancer activity of some new heterocyclic compounds based on 1-cyanoacetyl-3,5-dimethylpyrazole

Synthesis, biological activity, and in silico studies of thieno[2,3-d]pyrimidine and thieno[2,3-d]triazine derivatives

Synthesis, α-Glucosidase Inhibition, Anticancer, DFT and Molecular Docking Investigations of Pyrazole Hydrazone Derivatives

Synthesis and Biological Evaluation of Novel Steroidal Pyrazole Amides As Highly Potent Anticancer Agents.

Design and Synthesis of Pyrido[3,2-Α]carbazole Derivatives and Their Analogues As Potent Antitumour Agents.

Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells.

Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies.

Synthesis of New Pyrazole Hybrids as Potential Anticancer Agents with Xanthine Oxidase Inhibitory Activity

Novel pyrano[2,3-c]pyrazolopyrimidines as promising anticancer agents: Design, synthesis, and cell cycle arrest of HepG2 cells at S phase

Synthesis and Antiproliferative Activities of Novel Pyrrolotriazine Derivatives

Novel Coumarin‐Pyrazole‐Thiazoles Hybrids: Synthesis, Anticancer Activity, Molecular Docking and In Silico ADMET prediction Studies

Synthesis and Antitumor Activity of 5-(5-Halogenated-2-oxo-1h-pyrrolo[2,3-b]pyridin-(3z)-ylidenemethyl)-2,4-dimethyl-1h-pyrrole-3-carboxamides

Synthesis, photophysical properties, anticancer evaluation, and molecular docking studies of new pyrimidine linked 4‐arylidene‐thiazolidin‐4‐ones as potent anticancer agents

Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis

Design, synthesis and potent anti-pancreatic cancer activity of new pyrazole derivatives bearing chalcone, thiazole and thiadiazole moieties: gene expression, DNA fragmentation, cell cycle arrest and SAR